Outcome of breast cancer patients regarding obesity and complications: Analysis of risk factors

Introduction. Breast cancer is the leading cause of cancer death in Romania. In the context in which the treatments available for this pathology have increased curability, the identification of negative prognostic factors involved in the evolution of this disease seems essential to improve the overa...

Full description

Bibliographic Details
Main Authors: Iuliana Pantelimon, Laurentia Nicoleta Gales, Maria Daniela Tanasescu, Irina Nita, Loredana Sabina Cornelia Manolescu, Rodica Maricela Anghel
Format: Article
Language:English
Published: Amaltea Medical Publishing House 2021-03-01
Series:Romanian Medical Journal
Subjects:
Online Access:https://rmj.com.ro/articles/2021.1/RMJ_2021_1_Art-14.pdf
_version_ 1827362623569526784
author Iuliana Pantelimon
Laurentia Nicoleta Gales
Maria Daniela Tanasescu
Irina Nita
Loredana Sabina Cornelia Manolescu
Rodica Maricela Anghel
author_facet Iuliana Pantelimon
Laurentia Nicoleta Gales
Maria Daniela Tanasescu
Irina Nita
Loredana Sabina Cornelia Manolescu
Rodica Maricela Anghel
author_sort Iuliana Pantelimon
collection DOAJ
description Introduction. Breast cancer is the leading cause of cancer death in Romania. In the context in which the treatments available for this pathology have increased curability, the identification of negative prognostic factors involved in the evolution of this disease seems essential to improve the overall survival as well as the time to disease progression. Aim. The aim of this study is to identify the role of prognostic factors such as ki67 proliferation index, the presence of tumour estrogen receptors, HER2 overexpression, the presence of secondary determinations at diagnosis, the association of obesity and type II diabetes. Methods. 50 patients diagnosed with breast cancer treated in the Elias University Emergency Hospital Bucharest were retrospectively followed, for which the progression was documented at the time of elaboration of this study. Thus, a database was developed in which data were entered on age, body mass index, immunohistochemical characteristics of breast tumours, the presence/absence of metastases at diagnosis and the association of type II diabetes. Statistical calculations were performed to highlight a possible correlation between obesity (quantified by measuring body mass index) and tumour aggressiveness (quantified by ki67 proliferation index) as well as statistical evaluation of potential prognostic factors that would influence time, until the disease progresses. Results. Within this group, no correlation could be established between the presence of an increased body mass index and the value of the ki67 proliferation index (p = 0.38). The mean value of the body mass index for this group of unselected patients was 28.76 ± 4.81 (DS) most patients are therefore overweight or obese. The factors involved in the evolution of breast cancer that influenced the early progression of the disease were: the proliferation index ki67 (p <0.05), the presence of metastases at diagnosis (p < 0.0001) and the association of type II diabetes (p = 0.0085). The value of the body mass index did not influence the time to disease progression according to statistical calculations in this group probably due to the small number of normal weight patients included (p = 0.34).
first_indexed 2024-03-08T07:31:00Z
format Article
id doaj.art-4e0dcd21b7d34dce8d8f80e8c8bcee2c
institution Directory Open Access Journal
issn 1220-5478
2069-606X
language English
last_indexed 2024-03-08T07:31:00Z
publishDate 2021-03-01
publisher Amaltea Medical Publishing House
record_format Article
series Romanian Medical Journal
spelling doaj.art-4e0dcd21b7d34dce8d8f80e8c8bcee2c2024-02-02T20:25:10ZengAmaltea Medical Publishing HouseRomanian Medical Journal1220-54782069-606X2021-03-01681778610.37897/RMJ.2021.1.14Outcome of breast cancer patients regarding obesity and complications: Analysis of risk factorsIuliana Pantelimon0Laurentia Nicoleta Gales1Maria Daniela Tanasescu2Irina Nita3Loredana Sabina Cornelia Manolescu4Rodica Maricela Anghel5“Carol Davila“ University of Medicine and Pharmacy, Bucharest, Romania; Medical Oncology Department, “Cantacuzino“ Hospital, Bucharest, Romania“Carol Davila“ University of Medicine and Pharmacy, Bucharest, Romania; ”Prof. Dr. Alexandru Trestioreanu” Institute of Oncology, Bucharest, Romania“Carol Davila“ University of Medicine and Pharmacy, Bucharest, Romania; Department of Nephrology, University Emergency Hospital, Bucharest, Romania“Carol Davila“ University of Medicine and Pharmacy, Bucharest, Romania; Medical Oncology Department, Elias University Emergency Hospital, Bucharest, Romania“Carol Davila“ University of Medicine and Pharmacy, Bucharest, Romania“Carol Davila“ University of Medicine and Pharmacy, Bucharest, Romania; ”Prof. Dr. Alexandru Trestioreanu” Institute of Oncology, Bucharest, RomaniaIntroduction. Breast cancer is the leading cause of cancer death in Romania. In the context in which the treatments available for this pathology have increased curability, the identification of negative prognostic factors involved in the evolution of this disease seems essential to improve the overall survival as well as the time to disease progression. Aim. The aim of this study is to identify the role of prognostic factors such as ki67 proliferation index, the presence of tumour estrogen receptors, HER2 overexpression, the presence of secondary determinations at diagnosis, the association of obesity and type II diabetes. Methods. 50 patients diagnosed with breast cancer treated in the Elias University Emergency Hospital Bucharest were retrospectively followed, for which the progression was documented at the time of elaboration of this study. Thus, a database was developed in which data were entered on age, body mass index, immunohistochemical characteristics of breast tumours, the presence/absence of metastases at diagnosis and the association of type II diabetes. Statistical calculations were performed to highlight a possible correlation between obesity (quantified by measuring body mass index) and tumour aggressiveness (quantified by ki67 proliferation index) as well as statistical evaluation of potential prognostic factors that would influence time, until the disease progresses. Results. Within this group, no correlation could be established between the presence of an increased body mass index and the value of the ki67 proliferation index (p = 0.38). The mean value of the body mass index for this group of unselected patients was 28.76 ± 4.81 (DS) most patients are therefore overweight or obese. The factors involved in the evolution of breast cancer that influenced the early progression of the disease were: the proliferation index ki67 (p <0.05), the presence of metastases at diagnosis (p < 0.0001) and the association of type II diabetes (p = 0.0085). The value of the body mass index did not influence the time to disease progression according to statistical calculations in this group probably due to the small number of normal weight patients included (p = 0.34).https://rmj.com.ro/articles/2021.1/RMJ_2021_1_Art-14.pdfbreast cancerdiabeteski67obesity
spellingShingle Iuliana Pantelimon
Laurentia Nicoleta Gales
Maria Daniela Tanasescu
Irina Nita
Loredana Sabina Cornelia Manolescu
Rodica Maricela Anghel
Outcome of breast cancer patients regarding obesity and complications: Analysis of risk factors
Romanian Medical Journal
breast cancer
diabetes
ki67
obesity
title Outcome of breast cancer patients regarding obesity and complications: Analysis of risk factors
title_full Outcome of breast cancer patients regarding obesity and complications: Analysis of risk factors
title_fullStr Outcome of breast cancer patients regarding obesity and complications: Analysis of risk factors
title_full_unstemmed Outcome of breast cancer patients regarding obesity and complications: Analysis of risk factors
title_short Outcome of breast cancer patients regarding obesity and complications: Analysis of risk factors
title_sort outcome of breast cancer patients regarding obesity and complications analysis of risk factors
topic breast cancer
diabetes
ki67
obesity
url https://rmj.com.ro/articles/2021.1/RMJ_2021_1_Art-14.pdf
work_keys_str_mv AT iulianapantelimon outcomeofbreastcancerpatientsregardingobesityandcomplicationsanalysisofriskfactors
AT laurentianicoletagales outcomeofbreastcancerpatientsregardingobesityandcomplicationsanalysisofriskfactors
AT mariadanielatanasescu outcomeofbreastcancerpatientsregardingobesityandcomplicationsanalysisofriskfactors
AT irinanita outcomeofbreastcancerpatientsregardingobesityandcomplicationsanalysisofriskfactors
AT loredanasabinacorneliamanolescu outcomeofbreastcancerpatientsregardingobesityandcomplicationsanalysisofriskfactors
AT rodicamaricelaanghel outcomeofbreastcancerpatientsregardingobesityandcomplicationsanalysisofriskfactors